LIN SUE-JEAN — SEC Form 4 filings
SEC reporting owner CIK 1867788. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-06-18 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 30,218 shares, $898,542 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 25,272 shares @ $30.78 ($777,956) in Arcutis Biotherapeutics, Inc., filed 2025-11-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | Director | 5 | — | 2 legs · 30,218 sh · $898,542 | 10 |
| Stevanato Group S.p.A. (STVN) | Director | 1 | — | — | 1 |
Form 4 filings — LIN SUE-JEAN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-26 | 4 | Stevanato Group S.p.A. (STVN) | Grant/award (A): 4,975 @ $0 | EDGAR |
| 2026-06-17 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 4,946 @ $24.38 | EDGAR |
| 2026-06-09 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 5,778 @ $0 · Grant/award (A): 16,667 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 18,052 @ $8.63 · Option exercise (M): 7,220 @ $7.51 · Sale (S): 25,272 @ $30.78 · Option exercise (M): 18,052 (derivative) @ $0 · Option exercise (M): 7,220 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 7,609 @ $0 · Grant/award (A): 20,568 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 10,139 @ $0 · Grant/award (A): 27,052 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1867788 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →